UHSNYSEHealthcare

Public company intelligence preview

UNIVERSAL HEALTH SERVICES INC

122 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
122
5 filed in the last 30 days
Acquisition / disposition count
47/75
Buy / Sell
Unique insiders active in the last year
10
Current insider positions tracked
23
13 active, 10 exited

Insider compensation

Public aggregate: $6.1M average total compensation across covered insiders.

Governance movement

Public aggregate: 3 governance events in the last year.

Institutional ownership

Public aggregate: 678 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
4
Restricted-sale insiders, 1Y
2
Planned sale shares, 1Y
5.5K
Planned sale value, 1Y
$1.2M
Insiders covered
6
Latest year: 2025
Personnel changes, 1Y
3
Board appointments, 1Y
1
Board departures, 1Y
1

Market context

Basic quote context for the preview.

Price
$154.90
Market cap
$9.6B
Volume
31,699.913
EPS
$5.65
Revenue
$4.5B
Employees
101.5K

Company note

Context before the data.

Company Overview

Universal Health Services Inc. is a large diversified healthcare operator in the Healthcare sector and Medical Care Facilities industry, running acute care hospitals, outpatient centers, and a substantial behavioral health network. Based on its filing summaries, UHS operates across the U.S., Puerto Rico, Washington, D.C., and the U.K., with revenue heavily tied to patient volumes, payer mix, and government reimbursement programs. The business has recently shown strong momentum, with 2025 revenue growth driven by same-facility volume and pricing gains, contributions from new hospitals, and improving operating leverage. Its model depends on expanding facilities, recruiting clinicians, and maintaining strong managed care and government payer relationships in a highly regulated environment.

Executive Compensation Practices

For a company like UHS, executive compensation is likely to be anchored to financial and operating metrics that reflect hospital economics, such as revenue growth, adjusted admissions, patient days, same-facility performance, EBITDA or operating margin improvement, and cash flow generation. The 2025 filings show meaningful improvement in net income, pretax income, and operating margins, so incentive plans may reward management for both top-line growth and cost discipline, especially given ongoing labor inflation and reimbursement pressure. Because UHS is capital-intensive and regularly opens or acquires new facilities, compensation may also incorporate strategic milestones such as successful hospital launches, occupancy ramp-up, and disciplined capital deployment. In this sector, boards often also weigh compliance and reimbursement risk, so executives may face performance metrics tied to regulatory outcomes, quality, and operating continuity rather than revenue alone.

Insider Trading Considerations

Insider trading patterns at UHS may be influenced by the company’s sensitivity to reimbursement policy, labor trends, and the timing of major facility openings or litigation developments. Because results can move with Medicaid and commercial payer mix, insiders may be especially cautious around earnings releases, policy announcements, and updates on state-directed payment programs or Medicaid-related legislation. The company’s recurring use of stock repurchases, combined with strong cash generation, can also affect trading activity and perceptions of valuation support. In the Medical Care Facilities industry, executives and directors may hold meaningful positions but often trade under tighter blackout windows due to frequent regulatory, reimbursement, and legal developments that can materially affect reported results.

Unlock the full UHS insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.